TCL Archive FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court. January 15, 2010
TCL Archive NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors October 2, 1987
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005